GlassScriptPhysician profile
Arlene D Conte
NPI 1033102835
$3,626.96
in general payments reported to CMS, 2019-2025
44 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $708 · 2023: $550 · 2024: $924 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,795.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $395.11 | 2021-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $304.72 | 2023-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $242.95 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $222.87 | 2021-2025 | |
| Abbvie INC. | $221.86 | 2022-2025 | Linzess, Viberzi, Creon |
| Astrazeneca Pharmaceuticals LP | $214.46 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Abbott Laboratories | $208.98 | 2023-2025 | Freestyle Libre 3, Jot Dx, Id Now Instrument |
| Sumitomo Pharma America, INC. | $190.97 | 2023-2025 | Gemtesa |
| Eisai INC. | $116.79 | 2024-2025 | |
| Medtronic, INC. | $99.48 | 2024-2025 | Resolute Onyx, Minimed 780g, Symplicity G3 |
| Lundbeck LLC | $93.70 | 2023-2025 | Rexulti |
| Inspire Medical Systems, INC. | $84.62 | 2023-2025 | Inspire |
| Sunovion Pharmaceuticals INC. | $82.74 | 2022 | |
| Lilly USA, LLC | $81.75 | 2021-2025 | Zepbound, Mounjaro, Kisunla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.66 | 2022-2023 | Xifaxan, Trulance |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Conte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.